Management of Dyslipidemia Associated with Anti-Retroviral Therapy in HIV/AIDS Patients

Debrina Kusuma Devi, Erwin Astha Triyono, Musofa Rusli

Abstract

Dyslipidemia is a lipid metabolism disorder characterized by increased and decreased lipid fractions in plasma, including elevated total cholesterol, low-density lipoprotein (LDL) cholesterol, TG, and decreased HDL cholesterol. Dyslipidemia often occurs in patients with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS), especially those who have received anti-retroviral therapy (ARV). Various ARVs can cause dyslipidemia and the most common is the Protease Inhibitor group. Dyslipidemia is an important risk factor for cardiovascular events. Management of dyslipidemia in HIV-infected patients receiving antiretroviral therapy includes lifestyle modification, switching of antiretroviral drugs, and the use of lipid-lowering drugs as targeted by the recommendations of the NCEP ATP III

Download


Paper Citation


in Harvard Style

Devi D., Triyono E. and Rusli M. (2017). Management of Dyslipidemia Associated with Anti-Retroviral Therapy in HIV/AIDS Patients.In Proceedings of the International Meeting on Regenerative Medicine - Volume 1: IMRM, ISBN 978-989-758-334-6, pages 461-468. DOI: 10.5220/0007323104610468


in Bibtex Style

@conference{imrm17,
author={Debrina Kusuma Devi and Erwin Astha Triyono and Musofa Rusli},
title={Management of Dyslipidemia Associated with Anti-Retroviral Therapy in HIV/AIDS Patients},
booktitle={Proceedings of the International Meeting on Regenerative Medicine - Volume 1: IMRM,},
year={2017},
pages={461-468},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0007323104610468},
isbn={978-989-758-334-6},
}


in EndNote Style

TY - CONF

JO - Proceedings of the International Meeting on Regenerative Medicine - Volume 1: IMRM,
TI - Management of Dyslipidemia Associated with Anti-Retroviral Therapy in HIV/AIDS Patients
SN - 978-989-758-334-6
AU - Devi D.
AU - Triyono E.
AU - Rusli M.
PY - 2017
SP - 461
EP - 468
DO - 10.5220/0007323104610468